Fusion biopsy detects riskiest prostate cancers

/
Fusion biopsy detects riskiest prostate cancers

New imaging technologies involving MRI are emerging that are helping urologists more accurately target prostate cancer lesions in men diagnosed with prostate cancer. Over the past couple of years MRIs have become more refined, allowing for more accurate diagnoses of malignant tumors. Now, MRI is able to be fused with other new devices with real-time imaging produced by ultrasound. As a result, doctors are able to perform a biopsy with direct guidance of the needle to the suspicious lesion. The procedure is called a fusion biopsy.

Read More

New study: One orgasm a day could reduce prostate cancer risk

/
New study: One orgasm a day could reduce prostate cancer risk

Researchers claim that while an orgasm provides pleasure during sex, it may also reduce the risk for prostate cancer. It also provides a number of health benefits such as a boost in your immunity, better sleep, and can even protect against heart disease.

Read More

What do the different stages of prostate cancer mean?

/
What do the different stages of prostate cancer mean?

One in 7 men will be diagnosed with prostate cancer in their lifetime.  This means, you or someone you know will be diagnosed with prostate cancer at some point during your life.  Many people can find it confusing to sift through all the information out there, or perhaps don’t know where to start. Here is a guide to the different stages of prostate cancer and what they mean.  Hopefully this will help those looking for clearer information learn more about prostate cancer.

Read More

Hormone therapy for prostate cancer may increase Alzheimer’s risk

/
Hormone therapy for prostate cancer may increase Alzheimer’s risk

According to the lead author of the study, Dr. Kevin Nead of the University of Pennsylvania Perelman School of Medicine, "In this study, we did find that men who received hormone therapy had about an 88 percent increased risk of Alzheimer's disease.”

Read More

Black men with clinical prostatitis may have lower risk of prostate cancer

/
Black men with clinical prostatitis may have lower risk of prostate cancer

According to the American Cancer Society, prostate cancer is the second leading cause of cancer death in men in the United States, behind lung cancer. It is also the most common type of cancer in men other than skin cancer. And according to the Prostate Cancer Foundation, African-American men are nearly 1.6 times more likely to be diagnosed with prostate cancer than Caucasian men and 2.4 times more likely to die from the disease.

 

Read More

Top healthy food for Prostate

/
Top healthy food for Prostate

Cranberries, strawberries, blackberries, raspberries. Cranberries also helps bladder health by preventing bacteria from attaching to urinary tract walls. High in vitamin C and antioxidants. Vitamin C may help ease BPH symptoms by promoting urination and reducing swelling. Antioxidants prevent damage from free radicals – molecules that attack healthy cells and can contribute to cancer risk

Read More

Prostate cancer deaths linked to stress

/

Research suggests that having high levels of stress may increase a man’s risk of prostate cancer death. This includes men with advanced prostate cancer and localized prostate cancer.

Read More

With fewer PSA screenings, will more men die of prostate cancer?

/

There has been controversy over PSA screening for a number of years. The evidence began piling up about a decade ago that the PSA test leads to overdiagnosis and overtreatment. It is true that an elevated PSA may indicate prostate cancer. However, the PSA is not specific for prostate cancer and could also indicate other prostate related conditions. Many argue that prostate cancers are so slow growing that they may never even put a man’s health or life at risk, and that many men with prostate cancer will die with it, not of it.

Read More

Fewer Men are being screened for Prostate Cancer

/

Two new studies published on Tuesday in The Journal of the American Medical Association highlight that likely in accordance to USPSTF recommendations against screening, fewer men are being screened for prostate cancer and fewer cases of early state prostate cancer are being detected. The question is, if decreased screening is leading to a lower rate of diagnosis, what does this mean for the future of prostate cancer patients? 

Read More

Oncotype DX: A New Way to Diagnose Prostate Cancer

/
Oncotype DX: A New Way to Diagnose Prostate Cancer

A new genetic test has recently become available called Oncotype DX. The test is made by Genomic Health and will now be available at Dr. Samadi's Prostate Cancer Center in New York City. What is Oncotype DX?

Read More

MRI-Guided Biopsy detects locally recurrent prostate cancer

/
MRI-Guided Biopsy detects locally recurrent prostate cancer

Prostate cancer is the most common cancer in men. So far, the only tools available to detect and diagnose prostate cancer include: the PSA test and the transrectal ultrasound guided biopsy. Every year, about 20 million PSA tests are performed and about 1.2 million men undergo a biopsy. Traditional techniques such as the TRUS biopsy only sample the lower portion of the prostate – yet almost 30% of cancers are found outside this area. For this reason, only 30-40% of the 1.2 million biopsies performed on men each year are positive for prostate cancer.

Read More